- Home
- MNSB vs VIGL Comparison
MNSB vs VIGL Comparison
Compare MNSB & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNSB
- VIGL
- Stock Information
- Founded
- MNSB 2003
- VIGL 2020
- Country
- MNSB United States
- VIGL United States
- Employees
- MNSB N/A
- VIGL N/A
- Industry
- MNSB Major Banks
- VIGL Biotechnology: Pharmaceutical Preparations
- Sector
- MNSB Finance
- VIGL Health Care
- Exchange
- MNSB Nasdaq
- VIGL Nasdaq
- Market Cap
- MNSB 118.0M
- VIGL 134.9M
- IPO Year
- MNSB N/A
- VIGL 2022
- Fundamental
- Price
- MNSB $18.91
- VIGL $7.89
- Analyst Decision
- MNSB
- VIGL Buy
- Analyst Count
- MNSB 0
- VIGL 7
- Target Price
- MNSB N/A
- VIGL $8.00
- AVG Volume (30 Days)
- MNSB 24.2K
- VIGL 2.4M
- Earning Date
- MNSB 04-21-2025
- VIGL 05-07-2025
- Dividend Yield
- MNSB 2.10%
- VIGL N/A
- EPS Growth
- MNSB N/A
- VIGL N/A
- EPS
- MNSB N/A
- VIGL N/A
- Revenue
- MNSB $59,896,000.00
- VIGL N/A
- Revenue This Year
- MNSB $17.95
- VIGL N/A
- Revenue Next Year
- MNSB $2.52
- VIGL N/A
- P/E Ratio
- MNSB N/A
- VIGL N/A
- Revenue Growth
- MNSB N/A
- VIGL N/A
- 52 Week Low
- MNSB $15.00
- VIGL $1.31
- 52 Week High
- MNSB $20.88
- VIGL $7.95
- Technical
- Relative Strength Index (RSI)
- MNSB 50.86
- VIGL 90.42
- Support Level
- MNSB $18.68
- VIGL $2.23
- Resistance Level
- MNSB $19.90
- VIGL $7.95
- Average True Range (ATR)
- MNSB 0.56
- VIGL 0.13
- MACD
- MNSB -0.17
- VIGL 0.56
- Stochastic Oscillator
- MNSB 17.69
- VIGL 98.95
About MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.